Copertina

Effect of Antibiotics With Anaerobic Coverage on Graft‐Versus‐Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta‐Analysis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Hiroshi Ito, Yui Okamura, Yuna Tomura, Jura Oshida, Minori Fujita, Daiki Kobayashi
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Transplant Infectious Disease
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
di: Hiroki Hosoi, et al.
Pubblicazione: (2025)

Astrovirus Infection: A Rare Case of Digestive Infection After Allogeneic Stem Cell Transplantation That Can Lead to Graft‐Versus‐Host Disease
di: Caroline Noblet, et al.
Pubblicazione: (2025)

Analysis of Drug‐Resistant Bacteria Seasonality in Japan Using Financial Time Series Analysis Method: A Nationwide Longitudinal Study
di: Hiroshi Ito, et al.
Pubblicazione: (2025)

Molecular Profile and Dynamics of Commensal Viruses in Brazilian Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
di: Gabriel Montenegro de Campos, et al.
Pubblicazione: (2025)

Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia With Active Left Neck Tuberculosis: A Case Report
di: Ying He, et al.
Pubblicazione: (2025)

Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
di: Estela Giménez, et al.
Pubblicazione: (2025)

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis
di: Shio Yen Tio, et al.
Pubblicazione: (2025)

Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15‐Year Single‐Center Analysis
di: Jotaro Yamamoto, et al.
Pubblicazione: (2026)

Lung Biopsies in Patients Referred for Allogeneic Hematopoietic Cell Transplantation: Diagnostic Accuracy, Diagnostic Yield, and Clinical Utility
di: Sergio Rodriguez‐Rodriguez, et al.
Pubblicazione: (2026)

Aspergillus versicolor Meningitis in a Patient With Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation
di: Naonori Harada, et al.
Pubblicazione: (2025)

Preventing Cat‐Astrophe: Toxoplasma Seroprevalence and Prophylaxis Adherence After Allogeneic Stem Cell Transplant
di: Manogna Metlapalli, et al.
Pubblicazione: (2026)

Invasive Fungal Disease in Allogeneic Hematopoietic Cell Transplantation: New Risk Factors and New Therapeutic Options in a Changing World
di: Abby P. Douglas, et al.
Pubblicazione: (2026)

Clinically Significant EBV Infection in Allogeneic Stem Cell Transplanted Children Receiving Letermovir as Primary CMV Prophylaxis
di: Christina Oikonomopoulou, et al.
Pubblicazione: (2025)

Cytomegalovirus Infection After CD‐34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
di: Brennan Collis, et al.
Pubblicazione: (2025)

Clinical Analysis of Tuberculosis in Children and Adolescents Treated for Malignancy or Undergoing Hematopoietic Cell Transplantation—A Multicenter Nationwide Study
di: Ewelina Truszkowska, et al.
Pubblicazione: (2025)

Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause‐or‐Consequence Dilemma
di: Renato Pascale, et al.
Pubblicazione: (2026)

Crusted Scabies with Facial Involvement in a Patient Following Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report
di: Yingying Qian, et al.
Pubblicazione: (2025)

The Unseen Battleground: How Anaerobic Antibiotics Shape GVHD Risk Post‐HSCT
di: Ildefonso Espigado, et al.
Pubblicazione: (2025)

Role of Fiberoptic Bronchoscopy in Decision‐Making in the Management of Post‐Hematopoietic Stem Cell Transplant Patients Presenting with Pulmonary Infiltrates: A Retrospective Cohort Study
di: Abdulla Mobeireek, et al.
Pubblicazione: (2025)

Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant Recipients
di: Fareed Khawaja, et al.
Pubblicazione: (2025)

Infection‐Associated Immune Reconstitution Inflammatory Syndrome in Hematopoietic Cell Transplantation
di: Mansi Chaturvedi, et al.
Pubblicazione: (2025)

Critique on “Infection‐Associated Immune Reconstitution Inflammatory Syndrome in Hematopoietic Cell Transplantation”
di: Javed Iqbal, et al.
Pubblicazione: (2025)

Collateral Damage: Unpacking Antibiotic Risks in Liver Transplantation
di: Hannah Imlay, et al.
Pubblicazione: (2025)

Reply to: Critique on “Infection‐Associated Immune Reconstitution Inflammatory Syndrome in Hematopoietic Cell Transplantation”
di: Mansi Chaturvedi, et al.
Pubblicazione: (2025)

Delabeling Antibiotic Allergy in the Solid Organ Transplant Population Using a Multiple Antibiotic Allergy Evaluation Strategy
di: Rebecca Lee, et al.
Pubblicazione: (2025)

Preemptive Rituximab for Epstein–Barr Virus Reactivation After Hematopoietic Cell Transplantation: Necessary for All?
di: Anna Beatriz Coelho de Souza, et al.
Pubblicazione: (2025)

Evaluation of Titer‐Proven Response Rates of Pediatric Hepatitis B‐Combination Vaccines in Adult Hematopoietic Cell Transplant Recipients
di: Charles M. Gallagher, et al.
Pubblicazione: (2025)

Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
di: Marilyne Daher, et al.
Pubblicazione: (2025)

Antibiotic Tolerability in Nocardia Infection Among Kidney Transplant Recipients: A Multicenter Cohort Study
di: M. Pérez‐Mir, et al.
Pubblicazione: (2026)

Characterization of Beta‐Lactam Allergy and Outcomes Associated With Perioperative Antibiotic Choice in Renal Transplant Recipients
di: Annelise Nolan, et al.
Pubblicazione: (2025)

Use of the QuantiFERON Monitor Assay to Predict Clinical Outcomes in Solid Organ and Hematopoietic Cell Transplant Recipients: A Scoping Review
di: Bradley J. Gardiner, et al.
Pubblicazione: (2025)

Barriers and facilitators to routine revaccination among adult Hematopoietic Cell Transplant survivors in the United States: A convergent mixed methods analysis
di: Mihkai Wickline, et al.
Pubblicazione: (2024)

International Survey on Antibiotic Prophylaxis Approaches for Solid Organ Transplant Recipients and Donors Colonized With Multidrug‐Resistant Organisms
di: Julia Bini Viotti, et al.
Pubblicazione: (2025)

No Increased Risk of Infection Following a Protocol Change to Decrease Duration of Perioperative Antibiotic Prophylaxis in Liver Transplantation
di: Hutton Brandon, et al.
Pubblicazione: (2026)

Impact of Severe Persistent BK Polyomavirus on Graft Function and Quality of Life Outcomes in Kidney Transplant Recipients
di: Emily M. Eichenberger, et al.
Pubblicazione: (2025)

Impact of Repeated Non‐Fatal Infections on Quality of Life and Graft Function in ABO‐Incompatible Kidney Transplants
di: Federica Bocchi, et al.
Pubblicazione: (2025)

A First Case of Bacterial Pericarditis Due to Campylobacter fetus Infection in a Kidney Transplant Recipient
di: Shota Obata, et al.
Pubblicazione: (2024)

NUDT15 Genetic Polymorphism as a Risk Factor for Early Neutropenia During Valganciclovir Prophylaxis in Lung Transplant Patients
di: Yurie Katsube, et al.
Pubblicazione: (2025)

Antibiotic Exposure and Risk of Allograft Rejection and Survival After Liver Transplant: An Observational Cohort Study From a Tertiary Referral Centre
di: Olivia C. Smibert, et al.
Pubblicazione: (2025)

Outcomes of Short Antibiotic Courses for Gram‐Negative Bloodstream Infections in Solid Organ Transplant Recipients—A Systematic Review and Meta‐Analysis
di: Muath Alotaibi, et al.
Pubblicazione: (2026)